Cysmic
Cysmic GmbH is a biomedical technology company specializing in advanced blood testing and hematological analysis through innovative microfluidic devices combined with artificial intelligence. Their flagship product, Erysense, is a point-of-care diagnostic platform that analyzes red blood cell shape and flow properties in microchannels mimicking human capillaries, enabling early disease detection, therapy monitoring, and blood quality assessment. The company integrates hardware prototyping, microfluidics development, and AI-driven cell classification to deliver precise, efficient, and accessible blood diagnostics. Cysmic has demonstrated scientific traction through peer-reviewed publications and participation in international conferences and tech events, positioning itself as a pioneer in blood flow research and diagnostics with applications in transfusion medicine, drug testing, and personalized healthcare.
Cysmic
Cysmic GmbH is a biomedical technology company specializing in advanced blood testing and hematological analysis through innovative microfluidic devices combined with artificial intelligence. Their flagship product, Erysense, is a point-of-care diagnostic platform that analyzes red blood cell shape and flow properties in microchannels mimicking human capillaries, enabling early disease detection, therapy monitoring, and blood quality assessment. The company integrates hardware prototyping, microfluidics development, and AI-driven cell classification to deliver precise, efficient, and accessible blood diagnostics. Cysmic has demonstrated scientific traction through peer-reviewed publications and participation in international conferences and tech events, positioning itself as a pioneer in blood flow research and diagnostics with applications in transfusion medicine, drug testing, and personalized healthcare.